Caspase-2 is required for DNA damage-induced expression of the CDK inhibitor p21WAF1/CIP1

被引:0
|
作者
D Sohn
W Budach
R U Jänicke
机构
[1] Laboratory of Molecular Radiooncology,
[2] Clinic and Policlinic for Radiation Therapy and Radiooncology,undefined
[3] University of Düsseldorf,undefined
[4] Universitätsstrasse 1,undefined
来源
关键词
apoptosis; cell cycle; translational control; 3′-UTR; p53; RAIDD;
D O I
暂无
中图分类号
学科分类号
摘要
Although caspase-2 represents the most conserved caspase across species and was the second caspase identified, its precise function remains enigmatic. In several cell types we show that knockdown of caspase-2 specifically impaired DNA damage-induced p21 expression, whereas overexpression of a caspase-2 mutant increased p21 levels. Caspase-2 did not influence p21 mRNA transcription; moreover, various inhibitors targeting proteasomal or non-proteasomal proteases, including caspases, could not restore p21 protein levels following knockdown of caspase-2. As, however, silencing of caspase-2 impaired exogenous expression of p21 constructs containing 3′-UTR sequences, our results strongly indicate that caspase-2 regulates p21 expression at the translational level. Intriguingly, unlike depletion of caspase-2, which prevented p21 expression and thereby reverted the γ-IR-induced senescent phenotype of wild-type HCT116 colon carcinoma cells into apoptosis, knockdown of none of the caspase-2-interacting components RAIDD, RIP or DNA-PKcs was able to mimic these processes. Together, our data suggest that this novel role of caspase-2 as a translational regulator of p21 expression occurs not only independently of its enzymatic activity but also does not require known caspase-2-activating platforms.
引用
收藏
页码:1664 / 1674
页数:10
相关论文
共 50 条
  • [21] The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy
    Al-Douahji, M
    Brugarolas, J
    Brown, PAJ
    Stehman-Breen, CO
    Alpers, CE
    Shankland, SJ
    KIDNEY INTERNATIONAL, 1999, 56 (05) : 1691 - 1699
  • [22] p21WAF1/CIP1 and cancer: A shifting paradigm?
    Gartel, Andrei L.
    BIOFACTORS, 2009, 35 (02) : 161 - 164
  • [23] Synergistic effects of dexamethasone and genistein on the expression of Cdk inhibitor p21WAF1/CIP1 in human hepatocellular and colorectal carcinoma cells
    Park, JH
    Oh, EJ
    Choi, YH
    Kang, CD
    Kang, HS
    Kim, DK
    Kang, KI
    Yoo, MA
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 18 (05) : 997 - 1002
  • [24] Detection of p21WAF1/Cip1 in brain metastases
    Ruan, S
    Fuller, G
    Levin, V
    Bruner, JM
    Zhang, W
    JOURNAL OF NEURO-ONCOLOGY, 1998, 37 (03) : 223 - 228
  • [25] Apoptosis inhibitory activity of p21WAF1/CIP1
    Javelaud, D
    Bensançon, F
    M S-MEDECINE SCIENCES, 2000, 16 (02): : 265 - 266
  • [26] P21Waf1/Cip1 and the prevention of oxidative stress
    Hershenson, MB
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2004, 286 (03) : L502 - L505
  • [27] p21WAF1/Cip1 - PCNA: Fatal attraction
    Galanos, Panagiotis
    Pappas, George
    Gorgoulis, Vassilis G.
    CELL CYCLE, 2016, 15 (23) : 3153 - 3154
  • [28] p21WAF1/CIP1基因与肿瘤
    翟友刚
    史朋
    谢忠平
    生命的化学, 2004, (06) : 505 - 507
  • [29] Detection of p21WAF1/Cip1 in brain metastases
    Sanbao Ruan
    Greg Fuller
    Victor Levin
    Janet M. Bruner
    Wei Zhang
    Journal of Neuro-Oncology, 1998, 37 : 223 - 228
  • [30] PKCdelta modulates p21WAF1/CIP1 ability to bind to Cdk2 during TNFα-induced apoptosis
    Oh, You-Take
    Chun, Kwang Hoon
    Lee, Seung Ki
    CANCER RESEARCH, 2006, 66 (08)